Serum Institute of India (SII) CEO Adar Poonawalla Wednesday said his firm has decided to reduce the price of its anti-coronavirus vaccine, Covishield, to the states from Rs 400 to Rs 300 per dose as a “philanthropic gesture”. The pharma giant has received flak over its different pricing of Covishield for the Centre and states, with many state governments calling for equal pricing of the vaccine. The Centre gets Covishield at Rs 150 per dose from SII.
